创模生物科技(北京)有限公司

CN / En

NEWS

What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-30 15:39
  • Views:

(Summary description)In the fields of life science research and drug development, in vitro killing experimental platforms are important tools for evaluating drug efficacy and studying cellular mechanisms. InnoModels Biotechnology (Beijing) Co., Ltd., with its strong research and innovation capabilities, has launched multiple in vitro killing experimental platforms, providing researchers with highly controllable and accurate experimental environments, greatly promoting the development of this field. This article will provide a detailed introduction to the characteristics of the InnoModels organism in vitro killing experimental platform.

What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company

(Summary description)In the fields of life science research and drug development, in vitro killing experimental platforms are important tools for evaluating drug efficacy and studying cellular mechanisms. InnoModels Biotechnology (Beijing) Co., Ltd., with its strong research and innovation capabilities, has launched multiple in vitro killing experimental platforms, providing researchers with highly controllable and accurate experimental environments, greatly promoting the development of this field. This article will provide a detailed introduction to the characteristics of the InnoModels organism in vitro killing experimental platform.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-30 15:39
  • Views:
Information

In the fields of life science research and drug development, in vitro killing experimental platforms are important tools for evaluating drug efficacy and studying cellular mechanisms. InnoModels Biotechnology (Beijing) Co., Ltd., with its strong research and innovation capabilities, has launched multiple in vitro killing experimental platforms, providing researchers with highly controllable and accurate experimental environments, greatly promoting the development of this field. This article will provide a detailed introduction to the characteristics of the InnoModels organism in vitro killing experimental platform.
1. Highly controllable experimental environment
One of the most significant features of the in vitro killing experimental platform of InnoModels Biotechnology is its highly controllable experimental environment. This platform can accurately regulate key factors such as temperature, humidity, and atmosphere to ensure the accuracy and reproducibility of experimental results. This precise regulation not only helps reduce experimental errors, but also enables researchers to more accurately simulate the in vivo environment and improve the physiological relevance of experimental results.
2. Supports multiple cell types
This platform supports applications for multiple cell types, including but not limited to tumor cells, primary cells, and immune cells. This broad applicability enables researchers to conduct extensive research in different fields, whether it is oncology, immunology, or drug development, and find suitable experimental models. Through mixed culture, such as PBMC tumor cell co culture, the platform can more accurately simulate the in vivo immune-mediated killing response, providing strong support for the research and development of immunotherapy.

 


3. Real time monitoring and data analysis
During the experiment, the in vitro killing experimental platform of InnoModels Biotechnology can monitor cell status and response in real time, while recording and analyzing data. This real-time feedback mechanism not only improves the efficiency and accuracy of the experiment, but also enables researchers to adjust the experimental plan in a timely manner and optimize the experimental conditions. The application of advanced detection technologies such as flow cytometry enables researchers to accurately distinguish between effector cells and target cells, and accurately evaluate the killing effect.
4. Advanced automation technology
This platform adopts advanced automation technology, making the experimental process more efficient and convenient. Automated operations not only reduce errors caused by human factors, but also improve the reliability and repeatability of experiments. In addition, the introduction of automation technology enables the platform to process large-scale experimental data, providing strong data support for new drug screening and drug mechanism research.
5. Wide range of application areas
The in vitro killing experimental platform of InnoModels Biotechnology has been widely used in multiple fields. In terms of drug screening, researchers can use this platform to evaluate the cytotoxicity and toxicity levels of drugs on cells, providing important data for safety assessment in the drug development process. In terms of immunological research, this platform can be used to evaluate the killing potential of immune cells against tumor cells, providing strong support for the development and evaluation of immunotherapy. In addition, the platform is widely used in the field of personalized medicine, tailoring treatment plans based on individual patients' immune responses to improve treatment outcomes.
epilogue
The in vitro killing experimental platform of InnoModels Biotechnology has demonstrated strong competitiveness in the fields of life science research and drug development due to its highly controllable experimental environment, support for multiple cell types, real-time monitoring and data analysis, advanced automation technology, and wide range of application areas. This innovative platform not only provides researchers with efficient and reliable experimental tools, but also promotes progress and development in the field of science. In the future, with the continuous advancement of technology and the deepening of applications, the in vitro killing experimental platform of InnoModels Biotechnology is expected to play an important role in more fields and make greater contributions to human health.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司